[Therapy of leishmaniasis in France: consensus on proposed guidelines].
Abstract
Healing of Old World cutaneous leishmaniasis in travelers treated with fluconazole: drug effect or spontaneous evolution?
Abstract
Early curative applications of the aminoglycoside WR279396 on an experimental Leishmania major-loaded cutaneous site do not impair the acquisition of immunity.
Abstract
LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014.
Abstract
Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis.
Abstract
Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis.
Abstract
Optimization of topical therapy for Leishmania major localized cutaneous leishmaniasis using a reliable C57BL/6 Model.
Abstract
Pseudomonas aeruginosa otochondritis complicating localized cutaneous leishmaniasis: prevention of mutilation by early antibiotic therapy.
Abstract
WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study.
Abstract
Topical paromomycin with or without gentamicin for cutaneous leishmaniasis.
Abstract